Leisure-time physical activity (PA) and exercise training are known to help maintain cognitive function in healthy older adults. However, relatively little is known about the effects of PA on cognitive function or brain function in those at increased risk for Alzheimer’s disease through the presence of the apolipoproteinE epsilon4 (APOE-ε4) allele, diagnosis of mild cognitive impairment (MCI), or the presence of metabolic disease. Here, we examine the question of whether PA and exercise interventions may differentially impact cognitive trajectory, clinical outcomes, and brain structure and function among individuals at the greatest risk for AD. The literature suggests that the protective effects of PA on risk for future dementia appear to be larger in those at increased genetic risk for AD. Exercise training is also effective at helping to promote stable cognitive function in MCI patients, and greater cardiorespiratory fitness is associated with greater brain volume in early-stage AD patients. In APOE-ε4 allele carriers compared to non-carriers, greater levels of PA may be more effective in reducing amyloid burden and are associated with greater activation of semantic memory-related neural circuits. A greater research emphasis should be placed on randomized clinical trials for exercise, with clinical, behavioral, and neuroimaging outcomes in people at increased risk for AD.
References
[1]
Sands, L.P.; Yaffe, K.; Lui, L.Y.; Stewart, A.; Eng, C.; Covinsky, K. The effects of acute illness on ADL decline over 1 year in frail older adults with and without cognitive impairment. J. Gerontol. 2002, 57, M449–M454, doi:10.1093/gerona/57.7.M449.
[2]
Yaffe, K.; Fox, P.; Newcomer, R.; Sands, L.; Lindquist, K.; Dane, K.; Covinsky, K.E. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 2002, 287, 2090–2097.
[3]
Yaffe, K.; Petersen, R.C.; Lindquist, K.; Kramer, J.; Miller, B. Subtype of mild cognitive impairment and progression to dementia and death. Dement. Geriatr. Cogn. Dis. 2006, 22, 312–319.
Bateman, R.J.; Xiong, C.; Benzinger, T.L.; Fagan, A.M.; Goate, A.; Fox, N.C.; Marcus, D.S.; Cairns, N.J.; Xie, X.; Blazey, T.M.; et al. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease. N. Engl. J. Med. 2012, 367, 795–804.
[7]
Woodard, J.; Seidenberg, M.; Nielson, K.A.; Smith, J.C.; Antuono, P.; Durgerian, S.; Guidotti, L.; Zhang, Q.; Butts, A.; Hantke, N.; et al. Prediction of cognitive decline in healthy older adults using fMRI. J. Alzheimers Dis. 2010, 21, 871–885.
[8]
Clark, C.M.; Davatzikos, C.; Borthakur, A.; Newberg, A.; Leight, S.; Lee, V.M.; Trojanowski, J.Q. Biomarkers for early detection of Alzheimer pathology. Neurosignals 2008, 16, 11–18, doi:10.1159/000109754.
[9]
Reiman, E.M.; Langbaum, J.B.; Tariot, P.N. Alzheimer’s prevention initiative: A proposal to evaluate presymptomatic treatments as quickly as possible. Biomark. Med. 2010, 4, 3–14, doi:10.2217/bmm.09.91.
[10]
Woodard, J.L.; Sugarman, M.A.; Nielson, K.A.; Smith, J.C.; Seidenberg, M.; Durgerian, S.; Butts, A.; Hantke, N.; Lancaster, M.; Matthews, M.A.; Rao, S.M. Lifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy aging. Curr. Alzheimer Res. 2012, 9, 436–446, doi:10.2174/156720512800492477.
[11]
Samitz, G.; Egger, M.; Zwahlen, M. Domains of physical activity and all-cause mortality: Systematic review and dose-response meta-analysis of cohort studies. Int. J. Epidemiol. 2011, 40, 1382–1400, doi:10.1093/ije/dyr112.
[12]
Blair, S.N.; Kohl, H.W., III; Paffenbarger, R.S., Jr.; Clark, D.G.; Cooper, K.H.; Gibbons, L.W. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989, 262, 2395–2401.
[13]
Kujala, U.M.; Kaprio, J.; Sarna, S.; Koskenvuo, M. Relationship of leisure-time physical activity and mortality: The Finnish twin cohort. JAMA 1998, 279, 440–444.
[14]
Liu, R.; Sui, X.; Laditka, J.N.; Church, T.S.; Colabianchi, N.; Hussey, J.; Blair, S.N. Cardiorespiratory fitness as a predictor of dementia mortality in men and women. Med. Sci. Sports Exerc. 2012, 44, 253–259.
[15]
Scarmeas, N.; Luchsinger, J.A.; Brickman, A.M.; Cosentino, S.; Schupf, N.; Xin-Tang, M.; Gu, Y.; Stern, Y. Physical activity and Alzheimer disease course. Am. J. Geriatr. Psychiatry 2011, 19, 471–481, doi:10.1097/JGP.0b013e3181eb00a9.
[16]
Pereira, A.C.; Huddleston, D.E.; Brickman, A.M.; Sosunov, A.A.; Hen, R.; McKhann, G.M.; Sloan, R.; Gage, F.H.; Brown, T.R.; Small, S.A. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc. Natl. Acad. Sci. USA 2007, 104, 5638–5643.
[17]
Cotman, C.W.; Berchtold, N.C. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002, 25, 295–301, doi:10.1016/S0166-2236(02)02143-4.
Colcombe, S.; Kramer, A.F. Fitness effects on the cognitive function of older adults: A meta-analytic study. Psychol. Sci. 2003, 14, 125–130, doi:10.1111/1467-9280.t01-1-01430.
[20]
Etnier, J.L.; Nowell, P.M.; Landers, D.M.; Sibley, B.A. A meta-regression to examine the relationship between aerobic fitness and cognitive performance. Brain Res. Rev. 2006, 52, 119–130, doi:10.1016/j.brainresrev.2006.01.002.
[21]
Kramer, A.F.; Erickson, K.I.; Colcombe, S.J. Exercise, cognition, and the aging brain. J. Appl. Physiol. 2006, 101, 1237–1242, doi:10.1152/japplphysiol.00500.2006.
[22]
Van Praag, H.; Kempermann, G.; Gage, F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat. Neurosci. 1999, 2, 266–270.
[23]
Erickson, K.I.; Voss, M.W.; Prakash, R.S.; Basak, C.; Szabo, A.; Chaddock, L.; Kim, J.S.; Heo, S.; Alves, H.; White, S.M.; et al. Exercise training increases size of hippocampus and improves memory. Proc. Natl. Acad. Sci. USA 2011, 108, 3017–3022.
Etgen, T.; Sander, D.; Huntgeburth, U.; Poppert, H.; Forstl, H.; Bickel, H. Physical activity and incident cognitive impairment in elderly persons: The INVADE study. Arch. Intern. Med. 2010, 170, 186–193, doi:10.1001/archinternmed.2009.498.
[27]
Laurin, D.; Verreault, R.; Lindsay, J.; MacPherson, K.; Rockwood, K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch. Neurol. 2001, 58, 498–504, doi:10.1001/archneur.58.3.498.
[28]
Etnier, J.L. Chronic exercise and cognition in older adults. In Exercise and Cognitive Function; McMorris, T., Tomporowski, P.D., Audiffren, M., Eds.; Wiley-Blackwell: Chichester, UK, 2009; pp. 227–248.
[29]
Sofi, F.; Valecchi, D.; Bacci, D.; Abbate, R.; Gensini, G.F.; Casini, A.; Macchi, C. Physical activity and risk of cognitive decline: A meta-analysis of prospective studies. J. Intern. Med. 2011, 269, 107–117, doi:10.1111/j.1365-2796.2010.02281.x.
[30]
Jack, C.R., Jr.; Knopman, D.S.; Jagust, W.J.; Shaw, L.M.; Aisen, P.S.; Weiner, M.W.; Petersen, R.C.; Trojanowski, J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010, 9, 119–128, doi:10.1016/S1474-4422(09)70299-6.
[31]
Chui, H.C.; Zheng, L.; Reed, B.R.; Vinters, H.V.; Mack, W.J. Vascular risk factors and Alzheimer’s disease: Are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res. Ther. 2012, 4, doi:10.1186/alzrt98.
[32]
Jack, C.R., Jr. Alzheimer disease: New concepts on its neurobiology and the clinical role imaging will play. Radiology 2012, 263, 344–361, doi:10.1148/radiol.12110433.
[33]
Corder, E.H.; Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.E.; Gaskell, P.C.; Small, G.W.; Roses, A.D.; Haines, J.L.; Pericak-Vance, M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993, 261, 921–923.
[34]
Balasubramanian, A.B.; Kawas, C.H.; Peltz, C.B.; Brookmeyer, R.; Corrada, M.M. Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia. Neurology 2012, 79, 915–921.
[35]
Ward, A.; Crean, S.; Mercaldi, C.J.; Collins, J.M.; Boyd, D.; Cook, M.N.; Arrighi, H.M. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer’s disease: A systematic review and meta-analysis. Neuroepidemiology 2012, 38, 1–17, doi:10.1159/000334607.
[36]
Raber, J.; Huang, Y.; Ashford, J.W. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol. Aging 2004, 25, 641–650, doi:10.1016/j.neurobiolaging.2003.12.023.
[37]
Cabeza, R.; Grady, C.L.; Nyberg, L.; McIntosh, A.R.; Tulving, E.; Kapur, S.; Jennings, J.M.; Houle, S.; Craik, F.I. Age-related differences in neural activity during memory encoding and retrieval: A positron emission tomography study. J. Neurosci. 1997, 17, 391–400.
[38]
Petersen, R.C.; Stevens, J.C.; Ganguli, M.; Tangalos, E.G.; Cummings, J.L.; Dekosky, S.T. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56, 1133–1142, doi:10.1212/WNL.56.9.1133.
[39]
Petersen, R.C. Mild cognitive impairment: Transition between aging and Alzheimer’s disease. Neurologia 2000, 15, 93–101.
[40]
DeKosky, S.T.; Marek, K. Looking backward to move forward: Early detection of neurodegenerative disorders. Science 2003, 302, 830–834.
[41]
Albert, M.S.; DeKosky, S.T.; Dickson, D.; Dubois, B.; Feldman, H.H.; Fox, N.C.; Gamst, A.; Holtzman, D.M.; Jagust, W.J.; Petersen, R.C.; et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011, 7, 270–279.
[42]
McKhann, G.M.; Knopman, D.S.; Chertkow, H.; Hyman, B.T.; Jack, C.R., Jr.; Kawas, C.H.; Klunk, W.E.; Koroshetz, W.J.; Manly, J.J.; Mayeux, R.; et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011, 7, 263–269.
[43]
Luchsinger, J.A.; Tang, M.X.; Stern, Y.; Shea, S.; Mayeux, R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 2001, 154, 635–641.
[44]
Grossman, H. Does diabetes protect or provoke Alzheimer’s disease? Insights into the pathobiology and future treatment of Alzheimer’s disease. CNS Spectr. 2003, 8, 815–823.
[45]
Yaffe, K.; Kanaya, A.; Lindquist, K.; Simonsick, E.M.; Harris, T.; Shorr, R.I.; Tylavsky, F.A.; Newman, A.B. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004, 292, 2237–2242.
[46]
Cukierman, T.; Gerstein, H.C.; Williamson, J.D. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia 2005, 48, 2460–2469.
[47]
Goveas, J.S.; Espeland, M.A.; Woods, N.F.; Wassertheil-Smoller, S.; Kotchen, J.M. Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: The Women’s Health Initiative Memory Study. J. Am. Geriatr. Soc. 2011, 59, 57–66.
[48]
Purnell, C.; Gao, S.; Callahan, C.M.; Hendrie, H.C. Cardiovascular risk factors and incident Alzheimer disease: A systematic review of the literature. Alzheimer Dis. Assoc. Disord. 2009, 23, 1–10, doi:10.1097/WAD.0b013e318187541c.
[49]
Etnier, J.L.; Caselli, R.J.; Reiman, E.M.; Alexander, G.E.; Sibley, B.A.; Tessier, D.; McLemore, E.C. Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness. Med. Sci. Sports Exerc. 2007, 39, 199–207.
[50]
Schuit, A.J.; Feskens, E.J.; Launer, L.J.; Kromhout, D. Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med. Sci. Sports Exerc. 2001, 33, 772–777.
[51]
Folstein, M.F.; Folstein, S.E.; McHugh, P.R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12, 189–198, doi:10.1016/0022-3956(75)90026-6.
[52]
Rovio, S.; Kareholt, I.; Helkala, E.L.; Viitanen, M.; Winblad, B.; Tuomilehto, J.; Soininen, H.; Nissinen, A.; Kivipelto, M. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer’s disease. Lancet Neurol. 2005, 4, 705–711, doi:10.1016/S1474-4422(05)70198-8.
[53]
Lindsay, J.; Laurin, D.; Verreault, R.; Hebert, R.; Helliwell, B.; Hill, G.B.; McDowell, I. Risk factors for Alzheimer’s disease: A prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 2002, 156, 445–453, doi:10.1093/aje/kwf074.
[54]
Podewils, L.J.; Guallar, E.; Kuller, L.H.; Fried, L.P.; Lopez, O.L.; Carlson, M.; Lyketsos, C.G. Physical activity, APOE genotype, and dementia risk: Findings from the Cardiovascular Health Cognition Study. Am. J. Epidemiol. 2005, 161, 639–651, doi:10.1093/aje/kwi092.
[55]
Rey, A. L’examen Clinique en Psychologie; Presses Universitaires de France: Paris, France, 1958.
[56]
Corwin, J.; Bylsma, F.W. “Psychological Examination Traumatic Encephalopathy” by A. Rey and “The Complex Figure Copy Test” by P.A. Osterrieth. Clin. Neuropsychol. 1993, 7, 3–21, doi:10.1080/13854049308401883.
[57]
Gromwall, D.M. Paced Auditory Serial Addition Task: A measure of recovery from concussion. Percept. Mot. Skills 1977, 44, 367–373, doi:10.2466/pms.1977.44.2.367.
[58]
Eggermont, L.H.; Swaab, D.F.; Hol, E.M.; Scherder, E.J. Walking the line: A randomised trial on the effects of a short term walking programme on cognition in dementia. J. Neurol. Neurosurg. Psychiatry 2009, 80, 802–804, doi:10.1136/jnnp.2008.158444.
[59]
Namazi, K.H.; Gwinnup, P.B.; Zadorozny, C.A. A low intensity exercise-movement program for patients with Alzheimer’s disease: The TEMP-AD protocol. J. Aging Phys. Act. 1994, 2, 80–92.
[60]
Rolland, Y.; Pillard, F.; Klapouszczak, A.; Reynish, E.; Thomas, D.; Andrieu, S.; Riviere, D.; Vellas, B. Exercise program for nursing home residents with Alzheimer’s disease: A 1-year randomized, controlled trial. J. Am. Geriatr. Soc. 2007, 55, 158–165, doi:10.1111/j.1532-5415.2007.01035.x.
[61]
Venturelli, M.; Scarsini, R.; Schena, F. Six-month walking program changes cognitive and ADL performance in patients with Alzheimer. Am. J. Alzheimers Dis. Dement. 2011, 26, 381–388, doi:10.1177/1533317511418956.
[62]
Yaguez, L.; Shaw, K.N.; Morris, R.; Matthews, D. The effects on cognitive functions of a movement-based intervention in patients with Alzheimer’s type dementia: A pilot study. Int. J. Geriatr. Psychiatry 2011, 26, 173–181, doi:10.1002/gps.2510.
[63]
Littbrand, H.; Stenvall, M.; Rosendahl, E. Applicability and effects of physical exercise on physical and cognitive functions and activities of daily living among people with dementia: A systematic review. Am. J. Phys. Med. Rehabil. 2011, 90, 495–518, doi:10.1097/PHM.0b013e318214de26.
Erickson, K.I.; Miller, D.L.; Weinstein, A.M.; Akl, S.L.; Banducci, S.E. Physical activity and brain plasticity in late adulthood: A conceptual review. Ageing Res. 2012, 3, doi:10.4081/ar.2012.e6.
[66]
Smith, P.J.; Blumenthal, J.A.; Hoffman, B.M.; Cooper, H.; Strauman, T.A.; Welsh-Bohmer, K.; Browndyke, J.N.; Sherwood, A. Aerobic exercise and neurocognitive performance: A meta-analytic review of randomized controlled trials. Psychosom. Med. 2010, 72, 239–252.
[67]
Angevaren, M.; Aufdemkampe, G.; Verhaar, H.J.; Aleman, A.; Vanhees, L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst. Rev. 2008, doi:10.1002/14651858.CD005381.pub2.
[68]
Scherder, E.J.; Van Paasschen, J.; Deijen, J.B.; Van Der Knokke, S.; Orlebeke, J.F.; Burgers, I.; Devriese, P.P.; Swaab, D.F.; Sergeant, J.A. Physical activity and executive functions in the elderly with mild cognitive impairment. Aging Ment. Health 2005, 9, 272–280.
[69]
Boule, N.G.; Kenny, G.P.; Haddad, E.; Wells, G.A.; Sigal, R.J. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 2003, 46, 1071–1081, doi:10.1007/s00125-003-1160-2.
[70]
Bouchard, C.; Sarzynski, M.A.; Rice, T.K.; Kraus, W.E.; Church, T.S.; Sung, Y.J.; Rao, D.C.; Rankinen, T. Genomic predictors of the maximal O2 uptake response to standardized exercise training programs. J. Appl. Physiol. 2011, 110, 1160–1170, doi:10.1152/japplphysiol.00973.2010.
[71]
Lautenschlager, N.T.; Cox, K.L.; Flicker, L.; Foster, J.K.; van Bockxmeer, F.M.; Xiao, J.; Greenop, K.R.; Almeida, O.P. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. J. Am. Med. Assoc. 2008, 300, 1027–1037, doi:10.1001/jama.300.9.1027.
[72]
Miller, L.A.; Spitznagel, M.B.; Busko, S.; Potter, V.; Juvancic-Heltzel, J.; Istenes, N.; Glickman, E.; Gunstad, J. Structured exercise does not stabilize cognitive function in individuals with mild cognitive impairment residing in a structured living facility. Int. J. Neurosci. 2011, 121, 218–223, doi:10.3109/00207454.2010.546537.
[73]
Baker, L.D.; Frank, L.L.; Foster-Schubert, K.; Green, P.S.; Wilkinson, C.W.; McTiernan, A.; Plymate, S.R.; Fishel, M.A.; Watson, G.S.; Cholerton, B.A.; et al. Effects of aerobic exercise on mild cognitive impairment: A controlled trial. Arch. Neurol. 2010, 67, 71–79.
Libon, D.J.; Xie, S.X.; Eppig, J.; Wicas, G.; Lamar, M.; Lippa, C.; Bettcher, B.M.; Price, C.C.; Giovannetti, T.; Swenson, R.; Wambach, D.M. The heterogeneity of mild cognitive impairment: A neuropsychological analysis. J. Int. Neuropsychol. Soc. 2010, 16, 84–93, doi:10.1017/S1355617709990993.
[76]
Morris, J.C. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Arch. Neurol. 2012, 69, 700–708.
[77]
Morris, J.C.; McKeel, D.W., Jr.; Storandt, M.; Rubin, E.H.; Price, J.L.; Grant, E.A.; Ball, M.J.; Berg, L. Very mild Alzheimer’s disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 1991, 41, 469–478, doi:10.1212/WNL.41.4.469.
[78]
Sperling, R.A.; Aisen, P.S.; Beckett, L.A.; Bennett, D.A.; Craft, S.; Fagan, A.M.; Iwatsubo, T.; Jack, C.R., Jr.; Kaye, J.; Montine, T.J.; et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011, 7, 280–292.
Vidoni, E.D.; Honea, R.A.; Billinger, S.A.; Swerdlow, R.H.; Burns, J.M. Cardiorespiratory fitness is associated with atrophy in Alzheimer’s and aging over 2 years. Neurobiol. Aging 2012, 33, 1624–1632, doi:10.1016/j.neurobiolaging.2011.03.016.
[84]
Head, D.; Bugg, J.M.; Goate, A.M.; Fagan, A.M.; Mintun, M.A.; Benzinger, T.; Holtzman, D.M.; Morris, J.C. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition. Arch. Neurol. 2012, 69, 636–643, doi:10.1001/archneurol.2011.845.
[85]
Deeny, S.P.; Poeppel, D.; Zimmerman, J.B.; Roth, S.M.; Brandauer, J.; Witkowski, S.; Hearn, J.W.; Ludlow, A.T.; Contreras-Vidal, J.L.; Brandt, J.; Hatfield, B.D. Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers. Biol. Psychol. 2008, 78, 179–187, doi:10.1016/j.biopsycho.2008.02.007.
[86]
Deeny, S.P.; Winchester, J.; Nichol, K.; Roth, S.M.; Wu, J.C.; Dick, M.; Cotman, C.W. Cardiovascular fitness is associated with altered cortical glucose metabolism during working memory in varepsilon4 carriers. Alzheimers Dement. 2012, 8, 352–356.
[87]
Aggarwal, N.T.; Wilson, R.S.; Beck, T.L.; Bienias, J.L.; Bennett, D.A. Mild cognitive impairment in different functional domains and incident Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 2005, 76, 1479–1484.
[88]
Trachtenberg, A.J.; Filippini, N.; Mackay, C.E. The effects of APOE-epsilon4 on the BOLD response. Neurobiol. Aging 2010, 33, 323–334.
[89]
Bondi, M.W.; Kaszniak, A.W. Implicit and explicit memory in Alzheimer’s disease and Parkinson’s disease. J. Clin. Exp. Neuropsychol. 1991, 13, 339–358, doi:10.1080/01688639108401048.
[90]
Irle, E.; Kaiser, P.; Naumann-Stoll, G. Differential patterns of memory loss in patients with Alzheimer’s disease and Korsakoff’s disease. Int. J. Neurosci. 1990, 52, 67–77, doi:10.3109/00207459008994245.
[91]
Petersen, R.C.; Smith, G.E.; Ivnik, R.J.; Kokmen, E.; Tangalos, E.G. Memory function in very early Alzheimer’s disease. Neurology 1994, 44, 867–872, doi:10.1212/WNL.44.5.867.
[92]
Nilsson, L.G. Memory function in normal aging. Acta Neurol. Scand. Suppl. 2003, 179, 7–13, doi:10.1034/j.1600-0404.107.s179.5.x.
[93]
Nielson, K.A.; Langenecker, S.A.; Garavan, H. Differences in the functional neuroanatomy of inhibitory control across the adult lifespan. Psychol. Aging 2002, 17, 56–57.
[94]
Persson, J.; Nyberg, L.; Lind, J.; Larsson, A.; Nilsson, L.G.; Ingvar, M.; Buckner, R.L. Structure-function correlates of cognitive decline in aging. Cereb. Cortex 2006, 16, 907–915.
[95]
Bookheimer, S.Y.; Strojwas, M.H.; Cohen, M.S.; Saunders, A.M.; Pericak-Vance, M.A.; Mazziotta, J.C.; Small, G.W. Patterns of brain activation in people at risk for Alzheimer’s Disease. N. Engl. J. Med. 2000, 343, 450–456, doi:10.1056/NEJM200008173430701.
[96]
O’Brien, J.L.; O’Keefe, K.M.; LaViolette, P.S.; DeLuca, A.N.; Blacker, D.; Dickerson, B.C.; Sperling, R.A. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 2010, 74, 1969–1976.
[97]
Lonie, J.A.; Herrmann, L.L.; Tierney, K.M.; Donaghey, C.; O’Carroll, R.; Lee, A.; Ebmeier, K.P. Lexical and semantic fluency discrepancy scores in aMCI and early Alzheimer’s disease. J. Neuropsychol. 2009, 3, 79–92, doi:10.1348/174866408X289935.
[98]
Henry, J.D.; Crawford, J.R.; Phillips, L.H. Verbal fluency performance in dementia of the Alzheimer’s type: A meta-analysis. Neuropsychologia 2004, 42, 1212–1222, doi:10.1016/j.neuropsychologia.2004.02.001.
[99]
Hodges, J.R.; Salmon, D.P.; Butters, N. Semantic memory impairment in Alzheimer’s disease: Failure of access or degraded knowledge? Neuropsychologia 1992, 30, 301–314, doi:10.1016/0028-3932(92)90104-T.
[100]
Hodges, J.R.; Salmon, D.P.; Butters, N. Differential impairment of semantic and episodic memory in Alzheimer’s and Huntington’s diseases: A controlled prospective study. J. Neurol. Neurosurg. Psychiatry 1990, 53, 1089–1095, doi:10.1136/jnnp.53.12.1089.
Lind, J.; Ingvar, M.; Persson, J.; Sleegers, K.; van Broeckhoven, C.; Adolfsson, R.; Nilsson, L.G.; Nyberg, L. Parietal cortex activation predicts memory decline in apolipoprotein E-epsilon4 carriers. Neuroreport 2006, 17, 1683–1686, doi:10.1097/01.wnr.0000239954.60695.c6.
[103]
Binder, J.R.; Desai, R.H.; Graves, W.W.; Conant, L.L. Where is the semantic system? A critical review and meta-analysis of 120 functional neuroimaging studies. Cereb. Cortex 2009, 19, 2767–2796, doi:10.1093/cercor/bhp055.
[104]
Buckner, R.L.; Snyder, A.Z.; Shannon, B.J.; LaRossa, G.; Sachs, R.; Fotenos, A.F.; Sheline, Y.I.; Klunk, W.E.; Mathis, C.A.; Morris, J.C.; Mintun, M.A. Molecular, structural, and functional characterization of Alzheimer’s disease: Evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 2005, 25, 7709–7717.
[105]
Hantke, N.; Nielson, K.A.; Woodard, J.L.; Breting, L.M.G.; Butts, A.; Seidenberg, M.; Smith, J.C.; Durgerian, S.; Lancaster, M.; Matthews, M.; et al. Comparison of semantic and episodic memory BOLD fMRI activation in predicting cognitive decline in older adults. J. Int. Neuropsychol. Soc. 2012, doi:10.1017/S1355617712000951.
[106]
Sugarman, M.A.; Woodard, J.L.; Nielson, K.A.; Seidenberg, M.; Smith, J.C.; Durgerian, S.; Rao, S.M. Functional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease risk. Biochim. Biophys. Acta 2012, 1822, 442–456.
[107]
Smith, J.C.; Nielson, K.A.; Woodard, J.L.; Seidenberg, M.; Durgerian, S.; Antuono, P.; Butts, A.M.; Hantke, N.C.; Lancaster, M.A.; Rao, S.M. Interactive effects of physical activity and APOE-epsilon4 on BOLD semantic memory activation in healthy elders. Neuroimage 2011, 54, 635–644, doi:10.1016/j.neuroimage.2010.07.070.
[108]
Taylor-Piliae, R.E.; Haskell, W.L.; Iribarren, C.; Norton, L.C.; Mahbouba, M.H.; Fair, J.M.; Hlatky, M.A.; Go, A.S.; Fortmann, S.P. Clinical utility of the Stanford brief activity survey in men and women with early-onset coronary artery disease. J. Cardiopulm. Rehabil. Prev. 2007, 27, 227–232.
[109]
Taylor-Piliae, R.E.; Norton, L.C.; Haskell, W.L.; Mahbouda, M.H.; Fair, J.M.; Iribarren, C.; Hlatky, M.A.; Go, A.S.; Fortmann, S.P. Validation of a new brief physical activity survey among men and women aged 60-69 years. Am. J. Epidemiol. 2006, 164, 598–606, doi:10.1093/aje/kwj248.
[110]
Park, D.C.; Reuter-Lorenz, P. The adaptive brain: Aging and neurocognitive scaffolding. Annu. Rev. Psychol. 2009, 60, 173–196, doi:10.1146/annurev.psych.59.103006.093656.
[111]
Stern, Y. What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 2002, 8, 448–460, doi:10.1017/S1355617702813248.
Crosson, B.; Benjamin, M.; Levy, I. Role of the basal ganglia in language and semantics: Supporting cast. In Neural Basis of Semantic Memory; Hart, J., Jr., Kraut, M.A., Eds.; Cambridge University Press: New York, NY, USA, 2007; pp. 219–243.
[116]
De Castro, J.M.; Duncan, G. Operantly conditioned running: Effects on brain catecholamine concentrations and receptor densities in the rat. Pharmacol. Biochem. Behav. 1985, 23, 495–500, doi:10.1016/0091-3057(85)90407-1.
[117]
Intlekofer, K.A.; Cotman, C.W. Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol. Dis. 2012, doi:10.1016/j.nbd.2012.06.011.
[118]
Van Praag, H.; Shubert, T.; Zhao, C.; Gage, F.H. Exercise enhances learning and hippocampal neurogenesis in aged mice. J. Neurosci. 2005, 25, 8680–8685, doi:10.1523/JNEUROSCI.1731-05.2005.
[119]
Trejo, J.L.; Carro, E.; Torres-Aleman, I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J. Neurosci. 2001, 21, 1628–1634.
[120]
Adlard, P.A.; Perreau, V.M.; Pop, V.; Cotman, C.W. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J. Neurosci. 2005, 25, 4217–4221.
[121]
Poirier, J. Apolipoprotein E and Alzheimer’s disease. A role in amyloid catabolism. Ann. N. Y. Acad. Sci. 2000, 924, 81–90, doi:10.1111/j.1749-6632.2000.tb05564.x.
[122]
Lane, R.M.; Farlow, M.R. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer’s disease. J. Lipid Res. 2005, 46, 949–968, doi:10.1194/jlr.M400486-JLR200.
[123]
Leduc, V.; Domenger, D.; de Beaumont, L.; Lalonde, D.; Belanger-Jasmin, S.; Poirier, J. Function and comorbidities of apolipoprotein e in Alzheimer’s disease. Int. J. Alzheimers Dis. 2011, 2011, doi:10.4061/2011/974361.
[124]
Ben, J.; Soares, F.M.; Cechetti, F.; Vuaden, F.C.; Bonan, C.D.; Netto, C.A.; Wyse, A.T. Exercise effects on activities of Na+,K+-ATPase, acetylcholinesterase and adenine nucleotides hydrolysis in ovariectomized rats. Brain Res. 2009, 1302, 248–255.
[125]
Fukao, K.; Shimada, K.; Naito, H.; Sumiyoshi, K.; Inoue, N.; Iesaki, T.; Kume, A.; Kiyanagi, T.; Hiki, M.; Hirose, K.; et al. Voluntary exercise ameliorates the progression of atherosclerotic lesion formation via anti-inflammatory effects in apolipoprotein E-deficient mice. J. Atheroscler. Thromb. 2010, 17, 1226–1236.
[126]
Rankinen, T.; Roth, S.M.; Bray, M.S.; Loos, R.; Perusse, L.; Wolfarth, B.; Hagberg, J.M.; Bouchard, C. Advances in exercise, fitness, and performance genomics. Med. Sci. Sports Exerc. 2010, 42, 835–846.
[127]
Leon, A.S.; Togashi, K.; Rankinen, T.; Despres, J.P.; Rao, D.C.; Skinner, J.S.; Wilmore, J.H.; Bouchard, C. Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE family study. Metabolism 2004, 53, 108–116, doi:10.1016/j.metabol.2003.08.013.
Hagberg, J.M.; Ferrell, R.E.; Katzel, L.I.; Dengel, D.R.; Sorkin, J.D.; Goldberg, A.P. Apolipoprotein E genotype and exercise training-induced increases in plasma high-density lipoprotein (HDL)- and HDL2-cholesterol levels in overweight men. Metabolism 1999, 48, 943–945, doi:10.1016/S0026-0495(99)90185-3.
[130]
Seip, R.L.; Otvos, J.; Bilbie, C.; Tsongalis, G.J.; Miles, M.; Zoeller, R.; Visich, P.; Gordon, P.; Angelopoulos, T.J.; Pescatello, L.; et al. The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise. Atherosclerosis 2006, 188, 126–133.
[131]
Crabbe, J.B.; Dishman, R.K. Brain electrocortical activity during and after exercise: A quantitative synthesis. Psychophysiology 2004, 41, 563–574, doi:10.1111/j.1469-8986.2004.00176.x.
